In our study, except for Cushing's syndrome, we also found the Glucagon signaling pathway in DE lncRNAs-enriched pathways and Type II diabetes mellitus in DE miRNA-enriched pathways, suggesting HYJJ might have regulation in CHF induced by Cushing's syndrome-related Type II diabetes. This evidence concerns the gene GCG and type 2 diabetes mellitus.